The next Symposium on Racing will include an all-day meeting on medication to be conducted by the American Association of Equine Practitioners. The Dec. 4 "summit" will look at the administration of therapeutic medications and discuss the standards and policies the industry should employ when treating horses for racing.
"There is growing interest in uniform national standards," Dr. C. Wayne McIlwraith, president of the AAEP, said in a prepared statement. "The Racehorse Medication Summit presents an opportunity to bring all the key stakeholders together to begin a constructive dialogue and reach our shared goals."
The AAEP last fall updated its medication policy to call for uniform standards for administering therapeutic medications, testing procedures, security measures, and enforcement policies by all racing jurisdictions. The policy calls for no raceday medications to be used except furosemide.